These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32292557)

  • 41. Targeting the SYK-BTK axis for the treatment of immunological and hematological disorders: recent progress and therapeutic perspectives.
    Tan SL; Liao C; Lucas MC; Stevenson C; DeMartino JA
    Pharmacol Ther; 2013 May; 138(2):294-309. PubMed ID: 23396081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Syk kinase inhibitors in allergic diseases.
    Denyer J; Patel V
    Drug News Perspect; 2009 Apr; 22(3):146-50. PubMed ID: 19440557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human spleen tyrosine kinase (Syk) recombinant expression systems for high-throughput assays.
    Singh D; Rani R; Rajendran R; Kaur NJ; Pandey A; Chopra P; Jain T; Jain MK; Grover S; Arya R; Saini KS
    Biotechnol J; 2010 Feb; 5(2):201-12. PubMed ID: 20013945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney.
    Ma FY; Blease K; Nikolic-Paterson DJ
    Life Sci; 2016 Feb; 146():192-200. PubMed ID: 26779657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic prospect of Syk inhibitors.
    Ruzza P; Biondi B; Calderan A
    Expert Opin Ther Pat; 2009 Oct; 19(10):1361-76. PubMed ID: 19670961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
    Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a pharmacodynamic assay based on PLCγ2 phosphorylation for quantifying spleen tyrosine kinase (SYK)-Bruton's tyrosine kinase (BTK) signaling.
    Hsu J; Zhang J; Kitson C; Tan SL; Narula S; DeMartino JA; Liao C
    J Biomol Screen; 2013 Sep; 18(8):890-8. PubMed ID: 23704133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
    Andorsky DJ; Kolibaba KS; Assouline S; Forero-Torres A; Jones V; Klein LM; Patel-Donnelly D; Smith M; Ye W; Shi W; Yasenchak CA; Sharman JP
    Br J Haematol; 2019 Jan; 184(2):215-222. PubMed ID: 30183069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syk kinase as a treatment target for therapy in autoimmune diseases.
    Kyttaris VC; Tsokos GC
    Clin Immunol; 2007 Sep; 124(3):235-7. PubMed ID: 17662659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Designing of new multi-targeted inhibitors of spleen tyrosine kinase (Syk) and zeta-associated protein of 70kDa (ZAP-70) using hierarchical virtual screening protocol.
    Kaur M; Kumari A; Bahia MS; Silakari O
    J Mol Graph Model; 2013 Feb; 39():165-75. PubMed ID: 23280414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis.
    Kurniawan DW; Jajoriya AK; Dhawan G; Mishra D; Argemi J; Bataller R; Storm G; Mishra DP; Prakash J; Bansal R
    J Control Release; 2018 Oct; 288():227-238. PubMed ID: 30219279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spleen tyrosine kinase-dependent Nrf2 activation regulates oxidative stress-induced cell death in WiL2-NS human B lymphoblasts.
    Park S; Jang JW; Moon EY
    Free Radic Res; 2018 Sep; 52(9):977-987. PubMed ID: 30203714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized Recipients.
    Ramessur Chandran S; Han Y; Tesch GH; Di Paolo J; Mulley WR; Kanellis J; Ma FY; Nikolic-Paterson DJ
    Transplantation; 2017 Aug; 101(8):e240-e248. PubMed ID: 28594748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients.
    Braegelmann C; Hölzel M; Ludbrook V; Dickson M; Turan N; Ferring-Schmitt S; Sternberg S; Bieber T; Kuhn A; Wenzel J
    Exp Dermatol; 2016 May; 25(5):375-9. PubMed ID: 26910509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy.
    Navara CS
    Curr Pharm Des; 2004; 10(15):1739-44. PubMed ID: 15180536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk.
    Zhao H; Caflisch A
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1523-7. PubMed ID: 24569110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of pyrazolopyridine derivatives as novel spleen tyrosine kinase inhibitors.
    Huang Y; Li Y; Dong G; Zhang W; Liu N; Sheng C
    Arch Pharm (Weinheim); 2018 Jun; ():. PubMed ID: 29952085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation.
    Wu NL; Huang DY; Wang LF; Kannagi R; Fan YC; Lin WW
    J Invest Dermatol; 2016 Jan; 136(1):192-201. PubMed ID: 26763439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spleen tyrosine kinase from Nile tilapia (Oreochromis niloticus): Molecular characterization, expression pattern upon bacterial infection and the potential role in BCR signaling and inflammatory response.
    Bian X; Wu L; Mu L; Yin X; Wei X; Zhong X; Yang Y; Wang J; Li Y; Guo Z; Ye J
    Fish Shellfish Immunol; 2018 Nov; 82():162-172. PubMed ID: 30114435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.